Li Auto Inc. Announces Results of Annual General Meeting
May 31, 2024 07:35 ET
|
Li Auto Inc.
BEIJING, China, May 31, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that each of the...
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
May 31, 2024 07:30 ET
|
Adaptive Biotechnologies
SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
May 31, 2024 07:30 ET
|
TG Therapeutics, Inc.
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs for post-marketing studies being undertaken for...
SciSparc Secures Strategic Advantage with Grant of European Patent
May 31, 2024 07:17 ET
|
SciSparc Ltd
TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
Draganfly to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, Presented by Maxim Group LLC
May 31, 2024 07:15 ET
|
Draganfly Inc
CEO Cameron Chell to Present Draganfly's Innovations in UAV Technology Saskatoon, SK, May 31, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), a leader in drone...
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial Monoclonal Antibodies
May 31, 2024 07:05 ET
|
Invivyd
Newly outlined pathway provides a practical, expedient, repeatable immunobridging approach to potential emergency use authorization of serial, novel monoclonal antibodies (mAbs) to prevent and treat...
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
May 31, 2024 07:00 ET
|
atai Life Sciences
NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental...
Village Farms International Amends and Extends Operating Loan
May 31, 2024 07:00 ET
|
Village Farms International, Inc.
VANCOUVER, British Columbia and ORLANDO, Fla.,, May 31, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF) announces it has amended and...
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
May 31, 2024 07:00 ET
|
Invivyd
Mr. Lee joins Invivyd with a history of high-quality commercial execution at Alexion, Biohaven and AmylyxAppointment intended to accelerate the addition of commercial capabilities associated with...
ECARX Antora 1000 Computing Platform to Power Geely Galaxy E5
May 31, 2024 07:00 ET
|
ECARX LIMITED
SHANGHAI, China, May 31, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced that its Antora 1000 computing...